BioCryst Pharmaceuticals, Inc.
(NASDAQ : BCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.26%83.050.9%$973.90m
KITEKite Pharma, Inc.
0.02%179.3316.1%$742.20m
CELGCelgene Corporation
0.47%144.561.1%$500.05m
AMGNAmgen Inc.
0.16%186.051.1%$483.92m
BIIBBiogen Inc.
-0.14%318.031.2%$421.79m
REGNRegeneron Pharmaceuticals, Inc.
1.45%439.002.7%$359.48m
ALNYAlnylam Pharmaceuticals, Inc
1.79%115.8410.7%$250.13m
ALXNAlexion Pharmaceuticals, Inc.
0.45%143.471.9%$230.02m
JUNOJuno Therapeutics, Inc.
-4.78%42.9814.6%$225.42m
VRTXVertex Pharmaceuticals Incorporated
-1.41%149.131.9%$208.39m
INCYIncyte Corporation
-1.30%109.412.6%$204.95m
ILMNIllumina, Inc.
-0.63%200.143.5%$158.40m
BLUEBluebird Bio, Inc.
1.28%130.4019.3%$143.26m
BMRNBioMarin Pharmaceutical Inc.
-0.69%94.304.4%$136.45m
CLVSClovis Oncology, Inc.
-2.95%76.2518.0%$132.43m

Company Profile

BioCryst Pharmaceuticals, Inc. engages in the research, development, and commercialization of biopharmaceutical products. Its portfolio includes Rapivab, Kallikrein inhibitors, and BCX4430. These drugs intend to treat influenza and hereditary angioedema. The company was founded in 1986 and is headquartered in Durham, NC.